4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOPB-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmActive, not recruitingPhase 22026-04-08NCT05798156
Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devicescardiovascular disorder, heart disorder, heart failureActive, not recruitingNot stated2026-02-12NCT03366545
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasmRecruitingPhase 32025-04-06NCT03643276
Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapycardiovascular disorder, heart disorder, heart failureActive, not recruitingNot applicable2024-01-05NCT04463641